Orthocell Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OCC.AX research report →
Price Chart
About the company
Headquartered in Murdoch, Australia, Orthocell Limited, established in 2006, operates as a regenerative medicine company focused on creating and bringing to market advanced cell therapies and biological medical devices. These innovations are designed to facilitate the healing of a range of bone and soft tissue injuries. The company's product lineup includes CelGro, a naturally derived collagen medical device engineered to augment surgical repair across various indications, including bone, peripheral nerves, tendons, and cartilage.
- CEO
- Paul Frederick Anderson
- IPO
- 2014
- Employees
- 37
- HQ
- Murdoch, WA, AU
Get TickerSpark's AI analysis on OCC.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $217.87M
- P/E
- -15.72
- PEG
- 0.14
- P/S
- 23.15
- P/B
- 4.82
- EV/EBITDA
- -13.81
- Div Yield
- 0.00%
- Gross Margin
- 37.14%
- Op Margin
- -180.91%
- Net Margin
- -132.65%
- ROE
- -44.80%
- ROIC
- -31.31%
Latest fiscal year · YoY change
- Revenue
- $7.55M+42.1%
- Gross Profit
- $4.80M+30.3%
- Op Income
- $-13,975,479
- Net Income
- $-8,566,640-19.3%
- EPS
- $-0.04-8.2%
- OCF Growth
- -33.5%
- FCF Growth
- -21.4%
- 52W High
- $1.60
- 52W Low
- $0.70
- 50D MA
- $0.76
- 200D MA
- $0.88
- Beta
- -0.07
- RSI (14)
- 57
- Avg Volume
- 329.91K
No earnings-call transcripts are available for OCC.AX yet.
- Free Float
- 84.0%
- Shares Outstanding
- 272.33M
- Float Shares
- 228.72M
Held by 1 ETFs
Biggest fund positions in OCC.AX by dollar value.
Our OCC.AX coverage
Recent articles, reports, and earnings notes.
No research on OCC.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OCC.AX report →Orthocell US expansion supports record revenue - ICYMI
proactiveinvestors.com · Jul 18
Twin Vee PowerCats shares surge after merger agreement to combine public company with USFM subsidiary
proactiveinvestors.com · Jul 13
Orthocell delivers record FY2026 revenue as US Remplir rollout accelerates
proactiveinvestors.com · Jul 13
Small Cap Watch: Orthocell posts record revenue and explorers advance Queensland and Greenland programs
proactiveinvestors.com · Jul 13
Microsoft axes 2% of workforce as 'AI is changing how work gets done'
proactiveinvestors.com · Jul 6
Nine Mile Metals signs market-making and media agreements
proactiveinvestors.com · Jul 3
Amazon AWS launches new AI engineering division with $1B commitment
proactiveinvestors.com · Jun 30
FTSE 100 Live: London blue-chips hit 10-week high as Sainsbury's and miners climb
proactiveinvestors.com · Jun 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.